Scion v. Abbott
This article was originally published in The Gray Sheet
Executive Summary
Scion Cardio-Vascular drops suit accusing Abbott of misappropriating Clo-Sur P.A.D. wound dressing trade secrets. The firm says it will conserve resources for marketing efforts (1"The Gray Sheet" Dec. 9, 2002, p. 18)...
You may also be interested in...
Scion Accuses Abbott Of Misappropriating Clo-Sur Wound Dressing Secrets
Scion Cardio-Vascular, Inc. is accusing Abbott Laboratories of lifting elements of its Clo-Sur P.A.D. marketing campaign, among other infractions, in a six-count complaint filed Nov. 22 in Miami federal court
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.